🇺🇸 Epinephrine 1:200,000 in United States

57 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 11 reports (19.3%)
  2. Drug Interaction — 10 reports (17.54%)
  3. Hypertensive Crisis — 6 reports (10.53%)
  4. Cardiac Arrest — 5 reports (8.77%)
  5. Dizziness — 5 reports (8.77%)
  6. Accidental Overdose — 4 reports (7.02%)
  7. Feeling Abnormal — 4 reports (7.02%)
  8. Hypertension — 4 reports (7.02%)
  9. Maternal Exposure During Pregnancy — 4 reports (7.02%)
  10. Off Label Use — 4 reports (7.02%)

Source database →

Epinephrine 1:200,000 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Epinephrine 1:200,000 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Epinephrine 1:200,000 in United States?

Rio de Janeiro State University is the originator. The local marketing authorisation holder may differ — check the official source linked above.